RAC 0.97% $1.54 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-216

  1. 1,244 Posts.
    lightbulb Created with Sketch. 2461
    Not just relevant to RAC but should be shared on multiple biotech pages as a means to understanding at least some of the mechanisms in cancer.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.